Victor A. Delgado-Gonzalez

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.

Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.

Journal: The Journal of clinical and aesthetic dermatology

Published: July 16, 2026

Effectiveness and Safety of Janus Kinase Inhibitors in Adults Aged ≥ 50 Years With Moderate-To-Severe Atopic Dermatitis and Substantial Cardiovascular Comorbidity: A Multicenter Real-World Study.

Effectiveness and Safety of Janus Kinase Inhibitors in Adults Aged ≥ 50 Years With Moderate-To-Severe Atopic Dermatitis and Substantial Cardiovascular Comorbidity: A Multicenter Real-World Study.

Journal: International journal of dermatology

Published: January 10, 2026

Minimal Disease Activity as a Therapeutic Goal in Atopic Dermatitis: Predictive Factors of Sustainability in a Multicenter Cohort.

Minimal Disease Activity as a Therapeutic Goal in Atopic Dermatitis: Predictive Factors of Sustainability in a Multicenter Cohort.

Journal: Dermatology and therapy

Published: December 28, 2025

Multicenter Retrospective Case Series on the Real-World Experience With Sonidegib for the Management of Gorlin Syndrome.

Multicenter Retrospective Case Series on the Real-World Experience With Sonidegib for the Management of Gorlin Syndrome.

Journal: The Australasian journal of dermatology

Published: June 27, 2025

Effectiveness and Safety of Upadacitinib in Adults Older Than 50 Years With Moderate-To-Severe Atopic Dermatitis: A Multicenter Study.

Effectiveness and Safety of Upadacitinib in Adults Older Than 50 Years With Moderate-To-Severe Atopic Dermatitis: A Multicenter Study.

Journal: International journal of dermatology

Published: March 11, 2025

Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group.

Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group.

Journal: International journal of dermatology

Published: January 24, 2024

Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study.

Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study.

Journal: International journal of dermatology

Published: November 04, 2023

[Translated article] Dupilumab to Treat Chronic Palmoplantar Eczema: A Retrospective Multicenter Cohort Study.

[Translated article] Dupilumab to Treat Chronic Palmoplantar Eczema: A Retrospective Multicenter Cohort Study.

Journal: Actas dermo-sifiliograficas

Published: June 01, 2023

Upadacitinib effectiveness in moderate-to-severe atopic dermatitis: A real-life multicentre and retrospective study.

Upadacitinib effectiveness in moderate-to-severe atopic dermatitis: A real-life multicentre and retrospective study.

Journal: The Australasian journal of dermatology

Published: May 11, 2023

A Fast-Growing Tumor on the Head of an Elderly Woman: Challenge.

A Fast-Growing Tumor on the Head of an Elderly Woman: Challenge.

Journal: The American Journal of dermatopathology

Published: June 15, 2022

A Fast-Growing Tumor on the Head of an Elderly Woman: Answer.

A Fast-Growing Tumor on the Head of an Elderly Woman: Answer.

Journal: The American Journal of dermatopathology

Published: June 15, 2022

Foreign-Body Reaction to Dermal Filler: Good Response to Treatment with Allopurinol.

Foreign-Body Reaction to Dermal Filler: Good Response to Treatment with Allopurinol.

Journal: Actas dermo-sifiliograficas

Published: June 06, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026